17:25 EST Biolase files to sell 2.22M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BIOL:
- Biolase announces pricing of $1.4M registered direct offering
- Biolase price target lowered to $3.00 from $5.00 at Maxim
- Biolase sees FY23 revenue growth 1%-3%, consensus $55.93M
- Biolase reports Q3 adjusted EPS ($2.87), consensus ($1.85)
- BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES